Feedback / Questions
elraglusib oral tablet - Actuate Therap
https://www.globenewswire.com/news-release/2026/01/21/3222807/0/en/Actuate-Therapeutics-Announces-Plans-to-Expand-Clinical-Pipeline-Advancing-Elraglusib-Tablet-into-a-Phase-1-2-Clinical-Program-in-Refractory-Cancers.html
Jan 21, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next